Znn3bq.jpeg
²é¿´: 2426  |  »Ø¸´: 26
µ±Ç°Ö÷ÌâÒѾ­´æµµ¡£
µ±Ç°Ö»ÏÔʾÂú×ãÖ¸¶¨Ìõ¼þµÄ»ØÌû£¬µã»÷ÕâÀï²é¿´±¾»°ÌâµÄËùÓлØÌû

johnzhl01

Ìú¸Ëľ³æ (ÖøÃûдÊÖ)

[½»Á÷] ¡¶´´ÐÂÒ©Îﻯѧ¡·Ó¢ÎÄÔ­°æÏÂÔØ

ÊéÃû Practice of Medicinal Chemistry, 2nd ed
ISBN-10 0-12-744481-5
×÷Õß C. Wermuth, ed.
³ö°æÉç Academic Press, 2003, 624 pp., hard cover
Ŀ¼
A Brief History Of Drugs; From Plant Extracts To DNA Technology.
Medicinal Chemistry: Definition And Objectives, The Three Main Phases Of Drug Activity, Drug And Diseases Classifications.
Measurement And Expression Of Drug Effects.
Drug Targets: Molecular Mechanisms Of Drug Action.
Strategies In The Search For New Lead Compounds Or Original Working Hypotheses.
Natural Products As Pharmaceuticals And Sources For Lead Structures.
Basics Of Combinatorial Chemistry.
The Contribution Of Molecular Biology To Drug Discovery.
Electronic Screening: Lead Finding From Database Mining.
High-Speed Chemistry Libraries: Assessment Of Drug-Likeness.
Web Alert - Using The Internet For Medicinal Chemistry.
Molecular Variations In Homologous Series: Vinylogues And Benzologues.
Molecular Variations Based On Isosteric Replacements.
Ring Transformations.
Introduction Of Conformational Restriction And/Or Steric Hindrance.
Identical And Non Identical Twin Drugs.
Optical Isomerism In Drugs.
Application Strategies For The Primary Structure-Activity Relationship Exploration.
Specific Substituent Groups.
The Role Of Functional Groups In Drug¨CReceptor Interactions.
Compound Properties And Drug Quality.
Quantitative Approaches To Structure-Activity Relationships.
Structural Aspects Of Drug Action I.
Pharmacophore Identification And Receptor Mapping.
Three-Dimentional Quantitative Structure-Property Relationships.
Protein Crystallography And Drug Discovery.
Protein Comparative Modelling And Drug Discovery.
The Transition From Agonist To Antagonist Activity:
Symmetry And Other Considerations.
Design Of Peptidomimetics.
The Fate Of Xenobiotics In Living Organisms.
Biotransformation Reactions.
Chemical Mechanisms Of Toxicity.
Basic Knowledge For Designing Safer Drugs.
Designing Prodrugs And Bioprecursors.
Macromolecular Carriers For Drug Targeting.
Preparation Of Water Soluble Compounds Through Salt Formation.
Preparation Of Water-Soluble Compounds By Covalent Attachment Of Solubilizing Moieties.
Drug Solubilization With Organic Solvents, Surfactants And Lipids.
Improvement Of Drug Properties By Cyclodextrins.
Chemical And Physicochemical Solutions To Formulation Problems.
Discover A Drug Substance, Formulate And Develop It To A Product.
Drug Nomenclature.
Legal Aspects Of Product Protection.
The Consumption And Production Of Pharmaceuticals.


ÏÂÔØÁ´½Ó£º¡¡
http://a.thec.cn/fwangj/practice_of_medicinal_chemistry.pdf

[ Last edited by johnzhl01 on 2007-5-19 at 18:16 ]
»Ø¸´´ËÂ¥

» ²ÂÄãϲ»¶

¡¡¡¡¡¡¡¡¡¡¡¡*¡¡¡ï...*¡ï¡¡*.¡¡*..¡¡¡¡¡¡¡¡¡ï¡¡¡ï¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡¡*¡®*.¡¡¡¡¡¡¡¡¡¡¡¡¡¡*¡ï.¡¡¡¡¡®¡ï¡¡¡¡¡¡¡ï*'*...Suy,Äã¾ÍÊÇÎÒµÄÐÄ¡£
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

sofewind

Ìú³æ (³õÈëÎÄ̳)

0.25

Äܲ»ÄÜ·¢µ½ÎÒµÄemailÀï°¡!лл!
jinqiangzhu175@163.com
13Â¥2007-06-15 15:45:08
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
²é¿´È«²¿ 27 ¸ö»Ø´ð

³¯³¯ÓÚ

Ìú¸Ëľ³æ (ÕýʽдÊÖ)

²»ÄÜÏÂÔØÁË£¬ÇëÎÊÂ¥Ö÷¿É²»¿ÉÒÔ·¢µ½ÎÒµÄÓÊÏä°¡£¿
chenping0829@163.com
2Â¥2007-05-26 01:48:12
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

mike79

ľ³æ (ÖøÃûдÊÖ)

²»ÄÜÏÂÁË£¬Âé·³·¢Ò»Ï°ɣ¡
3Â¥2007-05-26 10:58:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû

chengwx

ľ³æ (ÖøÃûдÊÖ)

0.5

²»ÄÜÏÂÔØÁË£¬ÇëÎÊÂ¥Ö÷¿É²»¿ÉÒÔ·¢µ½ÎÒµÄÓÊÏä°¡£¿
wxcheng@sohu.com
4Â¥2007-05-29 16:58:27
ÒÑÔÄ   »Ø¸´´ËÂ¥   ¹Ø×¢TA ¸øTA·¢ÏûÏ¢ ËÍTAºì»¨ TAµÄ»ØÌû
×î¾ßÈËÆøÈÈÌûÍÆ¼ö [²é¿´È«²¿] ×÷Õß »Ø/¿´ ×îºó·¢±í
[¿¼ÑÐ] 271Çóµ÷¼Á +11 2261744733 2026-04-11 11/550 2026-04-11 11:19 by stone_128
[¿¼ÑÐ] »¯Ñ§308·ÖÇóµ÷¼Á +22 ÄãºÃÃ÷ÌìÄãºÃ 2026-04-07 24/1200 2026-04-11 11:14 by ChemPharm
[¿¼ÑÐ] 22408 352·ÖÇóµ÷¼Á +4 ŬÁ¦µÄÏÄÄ© 2026-04-09 4/200 2026-04-11 10:42 by maddjdld
[¿¼ÑÐ] ũѧ0904 312Çóµ÷¼Á +6 Say Never 2026-04-10 6/300 2026-04-11 10:33 by wwj2530616
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +17 ŬÁ¦·Ü¶·112 2026-04-06 20/1000 2026-04-11 00:31 by wangjihu
[¿¼ÑÐ] Ò»Ö¾Ô¸±±Àí¹¤298Ó¢Ò»Êý¶þÒÑÉϰ¶£¬¸Ðл¸÷λÀÏʦ +14 Reframe 2026-04-10 16/800 2026-04-10 23:07 by caotw2020
[¿¼ÑÐ] Çóµ÷¼Á +16 MAXâê㯠2026-04-09 18/900 2026-04-10 20:24 by С¹íม«¡«
[¿¼ÑÐ] 368Çóµ÷¼Á +3 17385968172 2026-04-10 3/150 2026-04-10 20:12 by µç×Ӱµ±ë
[¿¼ÑÐ] ±¾9 Ò»Ö¾Ô¸Î÷¹¤´ó085601 324Çóµ÷¼Á +5 wysyjs25 2026-04-10 5/250 2026-04-10 16:57 by luoyongfeng
[¿¼ÑÐ] µ÷¼Á +19 2261744733 2026-04-08 19/950 2026-04-09 19:11 by vgtyfty
[¿¼ÑÐ] 086000ÉúÎïÓëÒ½Ò©µ÷¼Á +7 awwwwwooooo 2026-04-09 7/350 2026-04-09 13:31 by ±±¼«159263
[¿¼ÑÐ] ÇóÖú071001µ÷¼Á£¡£¡£¡ +7 »ÆÊØËÉ 2026-04-05 8/400 2026-04-09 09:07 by ÐìÁ¼°×ü´óÏÀ
[¿¼ÑÐ] 327Çóµ÷¼Á +10 Xxjc1107. 2026-04-06 11/550 2026-04-09 01:21 by lature00
[¿¼²©] ²ÄÁÏ·½Ïò¿¼²©£¬ÇóÍÆ¼ö +3 ÑÔÓïaaa 2026-04-05 4/200 2026-04-08 22:22 by nxgogo
[¿¼ÑÐ] Ò»Ö¾Ô¸211£¬»¯Ñ§Ñ§Ë¶£¬310·Ö£¬±¾¿ÆÖصãË«·Ç£¬Çóµ÷¼Á +10 ŬÁ¦·Ü¶·112 2026-04-07 10/500 2026-04-08 15:01 by screening
[¿¼ÑÐ] »¯¹¤Ñ§Ë¶ 285Çóµ÷¼Á +26 Wisjxn 2026-04-07 26/1300 2026-04-08 14:42 by screening
[¿¼ÑÐ] 281Çóµ÷¼Á +10 Ò¬×ÓÄ¢¹½ 2026-04-06 10/500 2026-04-08 11:43 by zzucheup
[ÂÛÎÄͶ¸å] Decision: Revise for Editor»¹»áËÍÉóÂð 100+3 CccccccccFD 2026-04-04 5/250 2026-04-07 10:58 by ±±¾©À³ÒðÈóÉ«
[¿¼ÑÐ] ÉúÎïѧ308·ÖÇóµ÷¼Á£¨Ò»Ö¾Ô¸»ª¶«Ê¦´ó£© +8 ÏàÐűػá¹ââÍòÕ 2026-04-05 10/500 2026-04-05 12:19 by Hdyxbekcb
[¿¼ÑÐ] 323Çóµ÷¼Á +8 Àî¼ÑÀÖ1 2026-04-04 8/400 2026-04-04 22:26 by hemengdong
ÐÅÏ¢Ìáʾ
ÇëÌî´¦ÀíÒâ¼û